Seeking Alpha

Biolase (BIOL +36%) shares are soaring after the company received 510(k) clearance from the FDA...

Biolase (BIOL +36%) shares are soaring after the company received 510(k) clearance from the FDA for its EPIC 10 diode soft tissue laser, and began immediately offering the device for sale in the U.S. The company also received CE Mark approval for the laser in the European Union and began commercial sales there, as well as in Asian and Latin American countries that also recognize the CE Mark, during the final few days of its Q3.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector